A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
Clinical trial NCT03070964 · TERMINATED
Trial details
- NCT number
- NCT03070964
- Sponsor
- PharmaMar
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-25
- Primary completion
- 2018-07-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.